Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Paltusotine hydrochloride by Crinetics Pharmaceuticals for Carcinoid Syndrome (Malignant Carcinoid Syndrome): Likelihood of Approval
Paltusotine hydrochloride is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Carcinoid Syndrome (Malignant Carcinoid Syndrome)....
Data Insights
Paltusotine hydrochloride by Crinetics Pharmaceuticals for Carcinoid Syndrome (Malignant Carcinoid Syndrome): Likelihood of Approval
Paltusotine hydrochloride is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Carcinoid Syndrome (Malignant Carcinoid Syndrome)....